| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |